The leading global voice
We play a major role in bringing the CV community together to drive transformational change.
Together we are stronger
By 2025, our aim is to reduce premature deaths from CVD by at least 25%.
Join the fight
Become a WHF member and help us to build global commitment to address cardiovascular health at the policy level.
We convene and connect our members
To share science, best practice and resources, acting as a global thought leader and catalyst for positive change.
Celebrate World Heart Day
The biggest global awareness-raising campaign for CVD.
Attend the Congress
Join world leaders in heart health, share ideas, network with specialists.
Advocating for heart health
We lead the global advocacy effort for action to prevent, control and reduce the global burden of CVD.
All our programmes and partnerships are aimed at creating awareness of CVD as a priority issue across the globe.
Find out more about our and our members’ work around the world.
Explore everything from toolkits, videos and infographics, to policy reports, factsheets and more.
Meet our Emerging Leaders
Ambuj is interested in cardiovascular epidemiology and clinical trials. His research interest includes strengthening evidence based secondary prevention strategies and finding low cost solutions for cardiovascular interventions in the community in the developing countries. In this context, he has been the centre Principal Investigator of the UMPIRE Trial; which demonstrated that the polypill helps in improving compliance for secondary prevention; and also in the ongoing Yoga-Care Trial which envisages use of Yoga based cardiac rehabilitation. He has been earlier involved as a co-investigator in large multi-national studies like INTERHEART study, STICH Trial, FREEDOM Trial, CREATE Registry and ALTITUDE Diabetes study. In addition, he has a keen interest in cardiovascular epidemiology and is one of the lead investigators of a large study assessing the prevalence of coronary artery disease and its risk factors in urban and rural areas of Delhi and studying their secular trends. He is also the national Principal Investigator for the INTERCHF study, a large international registry of patients of congestive heart failure.
Anastase received his training in general medicine and internal medicine at the school of medicine of the Yaounde 1 University in his home country, before receiving further training in cardiovascular medicine at the Claude Bernard University in Lyon (France) where he acquired competence in cardiac pacing, cardiac and vascular ultrasound, and sports cardiology. He was laureate of the twin center fellowship of the World heart federation and is currently a fellow of the European Society of Cardiology, the Scientific secretary of the Cameroon Cardiac Society, chair of the task force on hypertension of the Pan-African Society of Cardiology, Regional Editor of the Cardiovascular Journal of Africa and editorial board member for Tropical cardiology. He has co-authored over 40 peer-reviewed publications and participated in a number of multicentric and international studies including THESUS-HF, RELY AF, PAPUCO I and II, and EIGHT. His current research focus include systemic hypertension, heart failure and pulmonary hypertension.
Cheryl is an Associate Professor of Preventive Medicine at the University of California San Diego (UCSD) School of Medicine. Her research focuses on diet and the prevention of cardiovascular disease, and she is an active researcher in cardiovascular epidemiology and has been an investigator on several observational epidemiologic studies and clinical trials. She is an active mentor and teacher, and served as the Director of the Bachelor of Science in Public Health program at UCSD from 2012-2014. Dr. Anderson is a Fellow of the American Heart Association where she serves on the leadership committees for the Epidemiology and Prevention Council and the Cardiometabolic Health and Lifestyle Council. She is also a member of the AHA’s National Research Committee. Dr. Anderson’s honors include the Gil Omenn Award for Academic Excellence, Dannon Nutrition Leadership Scholar, and a Volunteer Service Award from the National Kidney Foundation.
Deepak’s areas of research interest are in the epidemiology, prevention , task-shifting and implementation research pertaining to Non-Communicable Diseases (NCD), particularly cardiovascular disease (CVD). He researched medication adherence patterns and its determinants among heart failure patients as part of his M.D. dissertation. He has worked as a project officer for the NHLBI funded SPREAD study that aimed to improve adherence to medications and lifestyle modification in patients post Acute Coronary Syndromes using trained non-physician health workers. In this capacity, he had a key role developing the protocol and health worker training modules, training health workers, developing tools to improve patients’ medication adherence, developing data collection tools and coordinating the study. He is a co-investigator on a UK – Medical Research Council funded pilot project evaluating the feasibility of using trained peer mentors for CVD risk factor control at worksites in 3 South Asian countries (Bangladesh, Sri Lanka and India). He is also project officer for a large NHLBI funded nationwide stroke registry and several large primary CVD prevention trials.
Nammi is a primary care physician and researcher with a long-standing commitment to improving health and health care in communities that are affected by social inequality. In her current faculty position at Northwestern University, she leads research funded by the National Institutes of Health, on cardiovascular disease prevention in South Asian immigrants. Her research is shaped by two common and related aims: 1.Investigating the determinants of cardiovascular disease disparities using methods from epidemiology, health service research, and social sciences; and 2. Using community-engaged research methods to develop patient- centered cardiovascular disease prevention interventions for minority communities. The goal of her research is to ensure that minority communities benefit from biomedical research by moving scientific knowledge into action by explicitly integrating the patient perspective and the social and cultural context of health into cardiovascular disease prevention.
Rafael is a Cardiologist from Lugo, Spain. He studied Medicine at Universidad de Santiago de Compostela. In 2008 he specialized in Cardiology at Clínico Universitario de Santiago de Compostela, Spain. He is an active member of the Spanish Society of Cardiology in his web committee and former secretary of Cardiology Specialists in Training Council of Spanish Cardiology Society. He is also an active participant in the European Society of Cardiology (ESC) as Fellow and former nucleus of ESC Cardiologists of Tomorrow. His main field of research is cardiovascular risk factors and primary care and also topics like chronic ischaemic heart disease, diabetes, heart failure. During these last years, he was particularly involved in the management of observational studies at regional level with primary physicians and has published national and international peer-review academic papers in relation with these studies (http://www.researcherid.com/rid/B-5448-2012) and also his PhD dissertation was based in this research. Rafael believes in the usefulness of multinational studies.
Shariful Islam has previously worked as worked as a Team Leader and Medical Officer in UNDP Bangladesh, International Health Advisor, WHO, Project Officer, GiZ and Clinical Trial Physician, Texas Tech University, Lubbock, USA. His main areas of research are non-communicable diseases (NCDS), in particular diabetes and cardiovascular diseases, cardiovascular diabetology, hypertension, economic evaluations of NCDs, clinical epidemiology and health systems for NCDs. He is the Principal Investigator on a number of research grants and has published several peer-reviewed scientific papers in international journals. He has more than 50 scientific presentations in international conferences, organized and served as chair in several global health conferences. He has received several national and international awards, including gold-medal for academic excellence, Fogarty Fellowship, WHO Fellowship, Packard Award and DAAD Fellowship. Dr. Islam is a member of the editorial board of the British Journal of Medical Practitioners and WHO Bulletin.
Syed Shah is a physician specialized in community medicine and Associate Professor at the Institute of Public Health, College of Medicine and Health Sciences in United Arab Emirates University in Al Ain, Abu Dhabi. He completed his medical training in his home country of Pakistan and MPH in international health and PhD in Epidemiology from the School of Public Health, Health Sciences Center at Houston, University of Texas, USA. He was selected for Global Clinical Scholars Research Training Program, and completed a one year certification course on clinical trials from Harvard Medical School. Prior to his current work, he contributed in public health practice, research and teaching in the Department of Community Health Sciences at the Aga Khan University in Karachi, Pakistan, during 1990-1998, in Health and Safety Program, in Olympia, Washington State Government, USA, in 2001-2004, and in the Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Canada in 2004-2008. He is conducting community-based CVD prevention research in United Arab Emirates and in low-resource settings. He is one of the WHO nominated NCD Surveillance Specialist for countries in EMRO region.